Preference between precoital and daily use of Duet® and BufferGel in Zimbabwe

AIDS Behav. 2012 Oct;16(7):1799-807. doi: 10.1007/s10461-012-0256-4.

Abstract

Duet® is a microbicide-delivery system and cervical barrier for use daily or precoitally. We conducted a crossover study among 80 Zimbabwean women to explore factors associated with use-regimen preference. Women were assigned in random order to 14 days of precoital and 14 days of daily Duet and BufferGel use. About 51 % of women preferred precoital use, 39 % preferred daily use, and 10 % liked both equally. Overall product adherence during sex was similar for both use-regimens. In multivariable analysis, diaphragm experience was associated with preference for precoital use (AOR 2.80, 95 % CI 1.01-7.76). Reasons for preferring precoital use included use only when needed, cleanliness, and discomfort with daily use. Daily use preference included convenience, discreetness, and being prepared for "sex-on-demand." Different personal and life circumstances may result in varying use-regimen preferences. Methods that can accommodate both coitally-related and daily use may be advantageous by providing more choice to users.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylic Resins / administration & dosage*
  • Acrylic Resins / adverse effects
  • Adolescent
  • Adult
  • Anti-Infective Agents / administration & dosage*
  • Anti-Infective Agents / adverse effects
  • Coitus
  • Contraceptive Devices, Female / adverse effects
  • Contraceptive Devices, Female / statistics & numerical data*
  • Cross-Over Studies
  • Drug Delivery Systems / psychology
  • Female
  • Humans
  • Male
  • Patient Acceptance of Health Care
  • Patient Preference / psychology
  • Patient Preference / statistics & numerical data*
  • Sexual Partners
  • Socioeconomic Factors
  • Time Factors
  • Urban Population
  • Young Adult
  • Zimbabwe

Substances

  • Acrylic Resins
  • Anti-Infective Agents
  • BufferGel